A Phase 3, Randomized, Multi-Center, Open-Label Study To Evaluate the Efficacy and Safety of Leuprolide Acetate 11.25 and 30mg Formulation in Children with Central Precocious Puberty.
A Phase 3, Randomized, Multi-Center, Open-Label Study To Evaluate the Efficacy and Safety of Leuprolide Acetate 11.25 and 30mg Formulation in Children with Central Precocious Puberty.
© 2021 Latin Clinical Trial Center.
All Rights Reserved.
Powered By Millennial Networks